Antitumor and toxicologic properties of the organometallic anticancer agent vanadocene dichloride

M. Satya Murthy, Leela N. Rao, Louis Y. Kuo, Jeffrey H. Toney, Tobin J Marks

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

We report here on the antineoplastic, toxicologic, and transmembrane transfer properties of vanadocene dichloride (VDC), a representative metallocene dihalide. VDC is cytotoxic to HEp-2 human epidermoid carcinoma cells, in vitro, in a dose dependent manner, with a Do value (dose increment reducing the survival fraction by 1/e) of 0.530 ± 0.005 μg/ml. Under similar experimental conditions, the Do for cisplatin (CDDP) against these cells is 0.46 ± 0.08 μg/ml. In a murine mammary adenocarcinoma (TA3Ha) system, 125 μg/ml VDC inhibits the tumor-forming ability of 105 cells upon i.p. inoculation into syngeneic Strain A mice. The transmembrane transfer rate constants for the metal uptake of VDC and CDDP by TA3Ha cells in vitro were found to be 3.3 ± 0.8 × 10-4 min-1 and 12 ± 2.0 × 10t-4 min-1, respectively. In vivo studies with TA3Ha cells show that two i.p. treatments of 20, 40, and 60 mg/kg VDC increase the host survival by 30, 50, and 90%, respectively. Under similar conditions, 2, 4, and 6 mg/kg CDDP (equitoxic dose levels) prolong the host survival 50, 75, and 83%, respectively. Morphological, blood urea nitrogen level, and serum creatinine level data for Strain A mice treated with 60 mg/kg VDC give no evidence of renal or small intestinal damage. However, changes in the liver consistent with fatty cell degeneration are observed in these mice.

Original languageEnglish
Pages (from-to)117-124
Number of pages8
JournalInorganica Chimica Acta
Volume152
Issue number2
DOIs
Publication statusPublished - 1988

Fingerprint

dichlorides
Organometallics
Antineoplastic Agents
Urea
Liver
Cisplatin
mice
Tumors
Rate constants
cells
Blood
Cells
Nitrogen
dosage
Survival
Metals
creatinine
degeneration
Blood Urea Nitrogen
inoculation

ASJC Scopus subject areas

  • Biochemistry
  • Inorganic Chemistry
  • Physical and Theoretical Chemistry
  • Materials Chemistry
  • Medicine(all)

Cite this

Antitumor and toxicologic properties of the organometallic anticancer agent vanadocene dichloride. / Murthy, M. Satya; Rao, Leela N.; Kuo, Louis Y.; Toney, Jeffrey H.; Marks, Tobin J.

In: Inorganica Chimica Acta, Vol. 152, No. 2, 1988, p. 117-124.

Research output: Contribution to journalArticle

Murthy, M. Satya ; Rao, Leela N. ; Kuo, Louis Y. ; Toney, Jeffrey H. ; Marks, Tobin J. / Antitumor and toxicologic properties of the organometallic anticancer agent vanadocene dichloride. In: Inorganica Chimica Acta. 1988 ; Vol. 152, No. 2. pp. 117-124.
@article{2b34137e43834c0db81a724055b83b83,
title = "Antitumor and toxicologic properties of the organometallic anticancer agent vanadocene dichloride",
abstract = "We report here on the antineoplastic, toxicologic, and transmembrane transfer properties of vanadocene dichloride (VDC), a representative metallocene dihalide. VDC is cytotoxic to HEp-2 human epidermoid carcinoma cells, in vitro, in a dose dependent manner, with a Do value (dose increment reducing the survival fraction by 1/e) of 0.530 ± 0.005 μg/ml. Under similar experimental conditions, the Do for cisplatin (CDDP) against these cells is 0.46 ± 0.08 μg/ml. In a murine mammary adenocarcinoma (TA3Ha) system, 125 μg/ml VDC inhibits the tumor-forming ability of 105 cells upon i.p. inoculation into syngeneic Strain A mice. The transmembrane transfer rate constants for the metal uptake of VDC and CDDP by TA3Ha cells in vitro were found to be 3.3 ± 0.8 × 10-4 min-1 and 12 ± 2.0 × 10t-4 min-1, respectively. In vivo studies with TA3Ha cells show that two i.p. treatments of 20, 40, and 60 mg/kg VDC increase the host survival by 30, 50, and 90{\%}, respectively. Under similar conditions, 2, 4, and 6 mg/kg CDDP (equitoxic dose levels) prolong the host survival 50, 75, and 83{\%}, respectively. Morphological, blood urea nitrogen level, and serum creatinine level data for Strain A mice treated with 60 mg/kg VDC give no evidence of renal or small intestinal damage. However, changes in the liver consistent with fatty cell degeneration are observed in these mice.",
author = "Murthy, {M. Satya} and Rao, {Leela N.} and Kuo, {Louis Y.} and Toney, {Jeffrey H.} and Marks, {Tobin J}",
year = "1988",
doi = "10.1016/S0020-1693(00)83343-5",
language = "English",
volume = "152",
pages = "117--124",
journal = "Inorganica Chimica Acta",
issn = "0020-1693",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Antitumor and toxicologic properties of the organometallic anticancer agent vanadocene dichloride

AU - Murthy, M. Satya

AU - Rao, Leela N.

AU - Kuo, Louis Y.

AU - Toney, Jeffrey H.

AU - Marks, Tobin J

PY - 1988

Y1 - 1988

N2 - We report here on the antineoplastic, toxicologic, and transmembrane transfer properties of vanadocene dichloride (VDC), a representative metallocene dihalide. VDC is cytotoxic to HEp-2 human epidermoid carcinoma cells, in vitro, in a dose dependent manner, with a Do value (dose increment reducing the survival fraction by 1/e) of 0.530 ± 0.005 μg/ml. Under similar experimental conditions, the Do for cisplatin (CDDP) against these cells is 0.46 ± 0.08 μg/ml. In a murine mammary adenocarcinoma (TA3Ha) system, 125 μg/ml VDC inhibits the tumor-forming ability of 105 cells upon i.p. inoculation into syngeneic Strain A mice. The transmembrane transfer rate constants for the metal uptake of VDC and CDDP by TA3Ha cells in vitro were found to be 3.3 ± 0.8 × 10-4 min-1 and 12 ± 2.0 × 10t-4 min-1, respectively. In vivo studies with TA3Ha cells show that two i.p. treatments of 20, 40, and 60 mg/kg VDC increase the host survival by 30, 50, and 90%, respectively. Under similar conditions, 2, 4, and 6 mg/kg CDDP (equitoxic dose levels) prolong the host survival 50, 75, and 83%, respectively. Morphological, blood urea nitrogen level, and serum creatinine level data for Strain A mice treated with 60 mg/kg VDC give no evidence of renal or small intestinal damage. However, changes in the liver consistent with fatty cell degeneration are observed in these mice.

AB - We report here on the antineoplastic, toxicologic, and transmembrane transfer properties of vanadocene dichloride (VDC), a representative metallocene dihalide. VDC is cytotoxic to HEp-2 human epidermoid carcinoma cells, in vitro, in a dose dependent manner, with a Do value (dose increment reducing the survival fraction by 1/e) of 0.530 ± 0.005 μg/ml. Under similar experimental conditions, the Do for cisplatin (CDDP) against these cells is 0.46 ± 0.08 μg/ml. In a murine mammary adenocarcinoma (TA3Ha) system, 125 μg/ml VDC inhibits the tumor-forming ability of 105 cells upon i.p. inoculation into syngeneic Strain A mice. The transmembrane transfer rate constants for the metal uptake of VDC and CDDP by TA3Ha cells in vitro were found to be 3.3 ± 0.8 × 10-4 min-1 and 12 ± 2.0 × 10t-4 min-1, respectively. In vivo studies with TA3Ha cells show that two i.p. treatments of 20, 40, and 60 mg/kg VDC increase the host survival by 30, 50, and 90%, respectively. Under similar conditions, 2, 4, and 6 mg/kg CDDP (equitoxic dose levels) prolong the host survival 50, 75, and 83%, respectively. Morphological, blood urea nitrogen level, and serum creatinine level data for Strain A mice treated with 60 mg/kg VDC give no evidence of renal or small intestinal damage. However, changes in the liver consistent with fatty cell degeneration are observed in these mice.

UR - http://www.scopus.com/inward/record.url?scp=0023916711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023916711&partnerID=8YFLogxK

U2 - 10.1016/S0020-1693(00)83343-5

DO - 10.1016/S0020-1693(00)83343-5

M3 - Article

VL - 152

SP - 117

EP - 124

JO - Inorganica Chimica Acta

JF - Inorganica Chimica Acta

SN - 0020-1693

IS - 2

ER -